|
Why would anyone buy this company? No real marketable drugs worth over 40 million in sales, and no pipeline value. And to think Schering is interested now that they are being aquired by Merck is just a thoughtless observation.
Rating :
 (1 Rating) |
 |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.46